TG Therapeutics, Inc. ( NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the third quarter of 2026, along with recent company developments and provided an ...

UCB, a global biopharmaceutical company, today announced Week 24 data for BIMZELX® (bimekizumab-bkzx) from BE BOLD, building on the study's previously reported Week 16 results, which demonstrated ...

Even the ASPCA's plant list files its Prayer Plant entry under Calathea insignis, the rattlesnake plant, and lists Peacock ...

BND-67's dual mechanism of action enhances effector T-cell activity while reducing regulatory T-cell differentiation, aiming ...